Journal of cancer research and therapeuticsHumansEnhancer of Zeste Homolog 2 ProteinOropharyngeal NeoplasmsMaleChemoradiotherapy
Correlation of EZH2 expression and response to chemoradiation in patients with locally advanced inoperable oral cavity and oropharyngeal squamous cell cancers.
S K Soel Ahmed, Saroj Kumar Das Majumdar, Amit Kumar Adhya, Sandip Kumar Barik, Deepak Kumar Das, Mathan Kumar Ramasubbu, Priyanka Mukherjee, Anupam Muraleedharan, Nehla Haroon, Ankur Mahajan, Shaha Sheik Abdulla, Arnab Sarkar, Phanindra Kumar Swain, Pradipta Kumar Parida, Dillip Kumar Muduly
Published: 202510.4103/jcrt.jcrt_1467_25
Abstract
BACKGROUND: Head and neck cancer (HNC) is a major global health concern. Despite advances in treatment, the outcome is poor due to locoregional failure. Enhancer of zeste homolog 2 (EZH2), an epigenetic modifier, plays a role in cancer development by…
Preview only. Read the full abstract at the source